Daniel Herrera
Chief Growth Officer at MINDCURE- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Native or bilingual proficiency
-
French Native or bilingual proficiency
-
Spanish Professional working proficiency
-
Hebrew Limited working proficiency
Topline Score
Bio
Experience
-
MINDCURE
-
Canada
-
Mental Health Care
-
1 - 100 Employee
-
Chief Growth Officer
-
Feb 2022 - Present
-
-
VP, Growth & Strategic Partnerships
-
Mar 2021 - Feb 2022
- Responsible for Strategy development, feasibility, business development plan and milestones.- Lead strategic plan for drug development pipeline- Transfer to R&D for execution- Participate in preparation of capital raise activities- Commercial leadership on Digital health platform- Managing several projects simultaneously with project management skills to ensure tracking on time/budget and present to key stakeholders in timely manner.- Lead all business development activities with potential partners.- Coordinate cross-functional due diligence.- Support and sponsor the transition of projects throughout the development process.- Co-chair industry groups
-
-
-
Pinch Hitters Consultants
-
Canada
-
Pharmaceutical Manufacturing
-
Principal
-
Jan 2012 - Present
Strategic management consulting in biopharmaceutical and healthcare industries.Start-ups, capital raises, business planning and competitive analysis.Financial modeling, business analysis and planning, change management Strategic management consulting in biopharmaceutical and healthcare industries.Start-ups, capital raises, business planning and competitive analysis.Financial modeling, business analysis and planning, change management
-
-
-
Medcolcanna
-
Colombia
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Corporate Development Officer
-
Nov 2019 - Mar 2021
- Interfacing with Leadership Teams and across the Corporate matrix to ensure appropriate understanding of all key initiatives and organizational priorities.- Play central role in all planning functions and processes, budget, strategic planning, business reviews, business risk management and objective setting- Lead presentation to Board of Directors- Manage key investors and capital raise activities- Lead team responsible for strategic planning process and coordination from perspective of the global business operations in activities such as; Product Planning, Corporate Strategy, R&D Operations, Product in-licensing and out-licensing, project planning and management- Lead worldwide commercialization group to drive Corporate targets to achieve objectives of revenue and profitability.- Energizing and aligning organization around cultural initiatives.- Manage effectively all the external alliances and relationships in support of development and commercial activities.- Responsible for decision-making and communicating sense of urgency in meeting on all agreed upon objectives.- Responsible for representing the Company to external stakeholders including the capital markets
-
-
Vice President Of Business Development - USA/Europe
-
Nov 2019 - Mar 2021
-
-
-
CannTrust
-
Canada
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Director, Global Strategy & Business Development
-
Jun 2018 - Nov 2019
- Direct activities of R&D pipeline acquisition- Conduct strategic analysis of M&A activities- Participate in preparation for capital raise activities, including road show presentations, investor and analyst management- Direct a team of business development managers - Direct activities of R&D pipeline acquisition- Conduct strategic analysis of M&A activities- Participate in preparation for capital raise activities, including road show presentations, investor and analyst management- Direct a team of business development managers
-
-
-
Jubilant Radiopharma
-
United States
-
Pharmaceutical Manufacturing
-
300 - 400 Employee
-
Global Manager, Development & Strategy
-
Dec 2014 - Jun 2018
- Lead all portfolio activities and present to BoD- Responsible for business planning, budget and financial modeling for new to portfolio acquisitions- Sponsored internal research to support IP improvements of biopharma assets- Responsibility for Strategy development and presentation to key stakeholders- Strategy execution- Lead cross-functional team through the development process - Lead all portfolio activities and present to BoD- Responsible for business planning, budget and financial modeling for new to portfolio acquisitions- Sponsored internal research to support IP improvements of biopharma assets- Responsibility for Strategy development and presentation to key stakeholders- Strategy execution- Lead cross-functional team through the development process
-
-
-
Eli Lilly and Company
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Strategic Partnerships Development Manager
-
Jan 2013 - Dec 2014
-
-
National Marketing Manager - Cardiovascular
-
Apr 2011 - Jan 2013
-
-
Sales Associate, Hospital Specialty Business
-
Jan 2010 - Apr 2011
-
-
Medical Science Liaison
-
2009 - 2010
-
-
Specialty Sales Representative
-
2006 - 2009
-
-